United States · FDA National Drug Code directory
SEROQUEL XR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0310-0282_8e78eabf-6ff9-409b-ba1b-d9cb8d4f3fe0
- Product NDC
- 0310-0282
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- quetiapine
- Labeler
- AstraZeneca Pharmaceuticals LP
- Marketing category
- NDA
- Marketing start / end (source format)
- 20070716 / 20261231
Source-listed ingredients
- QUETIAPINE FUMARATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0310-0282-60) · 0310-0282-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →